Viking Therapeutics, Inc. (VKTX)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

11

0

2

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
20-Sep-24 9:21 PM View:	20-Sep-24 Planned Option Sale ($715.85K)	Singleton J Matthew Director		Viking Therapeutics, Inc. - VKTX	0% 9.5K	0	0	--	--	Show Txns Hide Txns

20-Sep-24 9:20 PM View:	20-Sep-24 Sale (Planned) ($3.54M)	Lian Brian President & CEO Director		Viking Therapeutics, Inc. - VKTX	4% 2.21M to 2.3M	0	0	--	--	Show Txns Hide Txns

08-Feb-24 7:38 PM View:	08-Feb-24 Planned Option Sale ($701.25K)	Rouan Sarah Kathryn Director		Viking Therapeutics, Inc. - VKTX	0% --	0	0	--	--	Show Txns Hide Txns

31-Jul-24 4:05 PM View:	30-Jul-24 Sale ($1.03M)	Mancini Marianna Chief Operating Officer		Viking Therapeutics, Inc. - VKTX	21% 298.87K to 362.15K	0	0	--	--	Show Txns Hide Txns

31-Jul-24 4:05 PM View:	30-Jul-24 Sale ($922.21K)	Zante Greg Chief Financial Officer		Viking Therapeutics, Inc. - VKTX	17% 160.39K to 187.05K	0	0	--	--	Show Txns Hide Txns